Ringnalda, Femke C. A. S. https://orcid.org/0000-0002-0684-4613
van Son, Gijs J. F. https://orcid.org/0000-0003-0572-3243
Verweij, Laurens H. G. https://orcid.org/0009-0004-5556-0256
Kim, Seok-Young https://orcid.org/0000-0001-8566-839X
Amo-Addae, Vicky
Flucke, Uta E.
Hiemcke–Jiwa, Laura S.
Langenberg, Karin P. S.
Bramer, Jos A. M.
Heimans, Lotte
van de Sande, Michiel A. J.
van Houdt, Winan J.
van Noesel, Max M.
Kerstens, Hinri H. D. https://orcid.org/0000-0003-2289-4108
Santoso, Marcel https://orcid.org/0009-0002-4433-9797
Seifert, Georg
Delattre, Olivier https://orcid.org/0000-0002-8730-2276
Scotlandi, Katia https://orcid.org/0000-0001-6114-9499
Geoerger, Birgit https://orcid.org/0000-0003-4361-3643
Merks, Johannes H. M. https://orcid.org/0000-0001-7659-1028
Molenaar, Jan J.
van Boxtel, Ruben https://orcid.org/0000-0003-1285-2836
van de Wetering, Marc https://orcid.org/0000-0002-8195-9939
Sanders, Karin https://orcid.org/0000-0001-9634-9853
Clevers, Hans https://orcid.org/0000-0002-3077-5582
Funding for this research was provided by:
Oncode Accelerator, Grant reference Number; NGFOP2201
Stichting Kinderen Kankervrij
Article History
Received: 5 September 2024
Accepted: 25 July 2025
First Online: 21 August 2025
Competing interests
: H.C. is an inventor on patents held by the Royal Netherlands Academy of Arts and Sciences that cover organoid technology. He is now head of Pharma Research and Early Development (pRED) at Roche, Basel, Switzerland. H.C.’s full disclosure is given at . All other authors declare that they have no competing interests.